Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

Affimed Appoints Annalisa Jenkins & Harry Welten to Board (2020-08-05)
Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointments of Dr. Annalisa Jenkins and Mr. Harry Welten to its Supervisory Board. Both these appointm...
Redx Signs Out Licensing Agreement with AstraZeneca (2020-08-04)
> AstraZeneca granted exclusive global licence for the development and commercialisation of RXC006, a porcupine inhibitor, for fibrotic diseases > Redx will receive up to $17 million in early payments between deal signature and the successful commencement of fir...
UCL Technology Fund: First Close of £100m Target Fund 2 (2020-08-03)
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB) (the university’s commercialisation company and part of UCL Innovation & Enterprise), announces first close of a £100m target Fund 2. The new fund will continue to support...
Sanofi & GSK: 100m Doses of COVID-19 Vaccine for US Govt (2020-07-31)
> Promising vaccine candidate selected by U.S. government’s Operation Warp Speed > U.S. government to provide funding up to $2.1 billion for development including clinical trials, manufacturing, scale-up and delivery of an initial 100 million doses > Ongoing ...
Sanofi & GSK Discuss COVID-19 Vaccine Supply with EU (2020-07-31)
> Discussions relate to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system > Both companies are committed to making their COVID-19 vaccine affordable and available globally Sanofi and GSK are i...
Genespire Appoints Jörn Aldag as Board Chairman (2020-07-30)
Serial entrepreneur brings exceptional experience from a range of leadership roles Genespire, a gene therapy company developing transformative therapies for genetic diseases, today announces the appointment of Jörn Aldag as Chairman of the Board. Jörn Aldag...
Abzena: $10m Growth Investment from Biospring Partners (2020-07-28)
Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based in...
Enthera Raises €28m Series A Co-led by Sofinnova & AbbVie (2020-07-28)
Enthera Pharmaceuticals (“Enthera”), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announces the completion ...
ExeVir Bio: First Closing of €23m Series A Led by Fund+ (2020-07-28)
- EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials - Technology Platform with Potential to Generate Robust Antiviral Therapies - Founded by VIB, UCB Ventures and Fund+ ExeVir Bio announces today a first closing ...
Apollo Therapeutics & UCLB Out-License Project to Deerfield (2020-07-21)
UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company, have completed the licensing of the first Ap...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top